Patent · US Active

Salts, co-crystals, and polymorphs of an anxiolytic compound

US10266529B2 · kind B2 · utility

0Cited by

1References

15Claims

0Family size

Assignees

Bionomics Limited · AU
IRONWOOD PHARMACEUTICALS, INC. · US

Inventors

Bernard Luke Flynn · Melbourne, AU
Dharam Paul · Yarrawonga, AU
Andrew John Harvey · Adelaide, AU
Vasu Sethuraman · Waltham, US
Raymond E. Forslund · Natick, US
Song Xue · Newton, US
Rob Livingston · Cambridge, US
Ahmad Hashash · Cambridge, US

Key dates

Filing date	Aug 25, 2017
Grant date	Apr 23, 2019
Priority date	—
Expiry date	Aug 25, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C55/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides crystalline Forms FUM-P3, FUM-P4, MLA-P3 and MLA-P4 of compound formula 1 and related methods of treating and/or preventing a disease, such as a central nervous system disease (e.g., an anxiety disorder), using a crystalline Form FUM-P3, FUM-P4, MLA-P3 and MLA-P4 of compound formula 1 and/or pharmaceutical compositions thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.